Dual LOX/COX inhibitors: potential novel anti-cancer drugs.
Vijayakrishnan
R
R
D000970:Antineoplastic Agents / Q000494:pharmacology*; D052246:Cyclooxygenase 2 Inhibitors; D015195:Drug Design; D006801:Humans; D016859:Lipoxygenase Inhibitors
D000970:Antineoplastic Agents; D052246:Cyclooxygenase 2 Inhibitors; D016859:Lipoxygenase Inhibitors